Clinical Services > Infection Control

Hepatitis cases of unknown origin raise concerns

02 May, 2022

More than 11 countries around the world, including the US, UK, Spain, Israel, Denmark, Norway and France among other countries, have reported acute, severe hepatitis of unknown origin.


Australian innovation delivering standardised frontline ultrasound infection prevention

01 May, 2022

In Australia, patients will suffer from an estimated 165,000 healthcare-associated infections (HAIs) each year.


New coating for implants, medical devices cuts infection risk

29 April, 2022

Infections after hip replacements and from orthopaedic device procedures can be complicated and lead to painful and repeat surgeries.


Drug-resistant environmental mould causes lung infections

27 April, 2022

Drug-resistant mould is spreading from the environment and infecting susceptible people's lungs, reveals a new study led by Imperial College London.


Proposal for assessing long COVID patients

26 April, 2022

A new assessment proposal aimed at clinicians and researchers hopes to help to establish an individualised treatment protocol for long COVID patients.


Delta variant's invasion trick to evade immune response

21 April, 2022

COVID-19's Delta variant may use a novel invasion method to evade the body's immune response, causing damage to the brain, intestine and kidneys, a Griffith University study has found.


Meningitis vaccines could help tackle untreatable gonorrhoea

13 April, 2022

Latest studies from South Australia and the US have indicated that meningitis vaccines could help improve protection against gonorrhoea.


UTIs are becoming more deadly, thanks to AMR — CSIRO

06 April, 2022

The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs) — which affect around one in two women and one in 20 men in their lifetime.


How can air purifiers help aged care facilities protect residents and staff from harmful viruses?

28 March, 2022 by Kate Smith, Head of Clinical Solutions, Training and Support – GAMA Healthcare (RN/RM, GCertNurs, Cert IV TAE)

As winter approaches, with its associated colds and flu, many aged care and long term care facilities will be looking for additional methods to protect their residents and staff.


COVID-19 taskforce publishes new risk classification tool

21 March, 2022

The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.


How antimicrobial resistance spreads inside the human gut

21 March, 2022

A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.


Shingrix approved for Australians 18+ at high risk

14 March, 2022

GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.


2022 influenza control: virologist recommends four actions

09 March, 2022

With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.


Mild COVID-19 linked to changes in brain structure: study

09 March, 2022

New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.


Hepatitis B: new recommendations for clinicians

07 March, 2022

New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd